🔎 Trials Near Me

Gara Jalqabaatti › Kansara Harkaa (Karsinomaa Seli Renal) › Alabama

Qorannoo klinikaalii Kansara Harkaa (Karsinomaa Seli Renal) Alabama keessatti

Qorannoo 7 Kansara Harkaa (Karsinomaa Seli Renal) f Alabama keessatti hirmaatuu jiru.

Magaalota Alabama keessatti

Takkalaa qorannoo (Ingiliffa)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, Birmingham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05536141

DESTINY-PANTUMOUR04

  • Research Site, Birmingham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

  • University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Cam-2026 · NCT05363280

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • University of Alabama at Birmingham, Birmingham
  • University of South Alabama, Mobile
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT05297734

Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

  • University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Onk-2025 · NCT06005818

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

  • University of Alabama at Birmingham Cancer Center, Birmingham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT04510597

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.